Anetumab Ravtansine
Anetumab Ravtansine Uses, Dosage, Side Effects, Food Interaction and all others data.
Anetumab Ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).
| Trade Name | Anetumab Ravtansine |
| Generic | Anetumab ravtansine |
| Anetumab ravtansine Other Names | Anetumab ravtansine, BAY 94-9343 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anetumab Ravtansine
